HHS Recovery Act Recipient Reporting Readiness Tool
Step 3. Select A Grant Award
Review the list of awards and select the Award Title link to see the required reporting data.
| DUNS Number | Award Number | Award Title | Agency | Fiscal Year | Issue Date | Funding Amount |
| 071284913 | 1P30CA149239-01 | CINCINNATI NEURO-ONCOLOGY RESEARCH CORE | NIH | 2009 | 09-30-2009 | $ 706,666 |
| 071284913 | 1P30HL101333-01 | DEVELOPMENT OF AN ASTHMA RESEARCH CORE CENTER | NIH | 2009 | 09-18-2009 | $ 548,775 |
| 071284913 | 1R01AG033057-01A1 | HOMEOSTASIS AND FUNCTION OF REGULATORY T CELLS IN AGING | NIH | 2009 | 09-01-2009 | $ 472,498 |
| 071284913 | 1R01AI078969-01A1 | INNATE IMMUNE RESPONSES DURING TOXOPLASMOSIS | NIH | 2009 | 08-28-2009 | $ 379,166 |
| 071284913 | 1R01AI080581-01 | ROLE OF IL-15 IN THE PATHOGENESIS OF EOSINOPHILIC ESOPHAGITIS (EE) | NIH | 2009 | 07-17-2009 | $ 371,814 |
| 071284913 | 1R01CA140518-01 | THE ROLE OF MLL-AF9 IN ACUTE MYELOID LEUKEMIA | NIH | 2009 | 07-14-2009 | $ 370,896 |
| 071284913 | 1R01DK081489-01A1 | GLOMERULOSCLEROSIS IN HUMAN FSGS AND ANIMAL MODELS | NIH | 2009 | 09-07-2009 | $ 346,760 |
| 071284913 | 1R01ES015517-01A1 | NEUROBEHAVIORAL EFFECTS OF INSECTICIDE EXPOSURE IN PREGNANCY AND EARLY CHILDHOOD | NIH | 2009 | 09-17-2009 | $ 750,890 |
| 071284913 | 1R01EY019377-01 | CRIM1-B-CATENIN-CADHERIN INTERACTIONS IN EYE DEVELOPMENT AND DISEASE | NIH | 2009 | 05-12-2009 | $ 375,000 |
| 071284913 | 1R01HD056044-01A2 | MOLECULAR SIGNALING IN DECIDUALIZATION | NIH | 2009 | 07-31-2009 | $ 566,211 |
| 071284913 | 1R01HD060578-01 | THE ROLES OF STEEL FACTOR IN GERM CELL BEHAVIOR IN THE MOUSE | NIH | 2009 | 07-23-2009 | $ 375,000 |
| 071284913 | 1R01HD065277-01 | 2/2 DEVELOPMENT OF A SCREENING INTERVIEW FOR RESEARCH STUDIES OF ASD | NIH | 2009 | 09-30-2009 | $ 364,291 |
| 071284913 | 1R01HL094319-01 | WNT SIGNALING IN HEART VALVE DEVELOPMENT AND DISEASE | NIH | 2009 | 05-29-2009 | $ 440,992 |
| 071284913 | 1R01HL097360-01 | DIRECT IL-4 AND IL-13 EFFECTS ON PULMONARY SMOOTH MUSCLE IN ALLERGIC AIRWAY DISEA | NIH | 2009 | 08-31-2009 | $ 473,954 |
| 071284913 | 1R03NS064378-01A1 | SHORT AND LONG-TERM IMPACT OF NEONATAL SEIZURES ON HIPPOCAMPAL GRANULE CELL INTEG | NIH | 2009 | 05-21-2009 | $ 75,000 |
| 071284913 | 1R21AI076746-01 | IDENTIFICATION OF GENES INVOLVED IN FHLH | NIH | 2009 | 08-28-2009 | $ 227,500 |
| 071284913 | 1R21AI083599-01 | RELM PEPTIDES ALTER LUNG DEFENSE | NIH | 2009 | 08-28-2009 | $ 189,583 |
| 071284913 | 1R21DA025312-01A1 | METABOLIC CONSEQUENCES OF SUBSTANCE USE IN ADOLESCENT GIRLS | NIH | 2009 | 05-05-2009 | $ 225,000 |
| 071284913 | 1R21ES016830-01A1 | EXPOSURE-INDUCED SYSTEMIC OXIDATIVE STRESS IN CHILDREN WITH ASTHMA | NIH | 2009 | 05-29-2009 | $ 225,000 |
| 071284913 | 1R21HD063275-01A1 | MEDIATING FACTORS IN THE RELATIONSHIP BETWEEN OBESITY AND POOR LACTATION OUTCOMES | NIH | 2010 | 09-07-2010 | $ 318,670 |
| 071284913 | 1R21NS064352-01 | THERAPY OF GAUCHER DISEASE: IN VIVO ENHANCEMENT OF RESIDUAL MUTANT ACTIVITY | NIH | 2009 | 05-01-2009 | $ 190,325 |
| 071284913 | 1RC1AI087336-01 | UNBIASED FORWARD GENETIC ANALYSIS OF VIRUS/HOST INTERACTIONS | NIH | 2009 | 09-18-2009 | $ 452,898 |
| 071284913 | 1RC1AR058587-01 | DEFINING THE COMPLEX GENETICS OF JIA | NIH | 2009 | 09-28-2009 | $ 500,000 |
| 071284913 | 1RC1HL100315-01 | UNBIASED GENOME-WIDE SCREEN TO IDENTIFY GENES REGULATING MUCOUS CELL HYPERPLASIA | NIH | 2009 | 09-17-2009 | $ 430,500 |
| 071284913 | 1RC1HL100474-01 | THE PEDIATRIC SEPSIS BIOMARKER RISK MODEL | NIH | 2009 | 09-15-2009 | $ 499,950 |
| 071284913 | 1RC4DK090891-01 | NEXTGEN DISSECTION OF THE GENOMIC BASIS OF KIDNEY DEVELOPMENT | NIH | 2010 | 09-29-2010 | $ 1,813,081 |
| 071284913 | 1S10RR027230-01 | ENTERPRISE RESEARCH DATA STORAGE FOR DATA-INTENSIVE COMPUTATION | NIH | 2010 | 02-20-2010 | $ 500,000 |
| 071284913 | 1U01AI088806-01 | A MULTI-CENTER CLINICAL TRIAL OF 1760 MCG OF DAILY SWALLOWED FLUTICASONE VS. PLAC | NIH | 2009 | 09-18-2009 | $ 620,683 |
| 071284913 | 1U01CA139275-01 | PREDICTION MODEL FOR RADIATION SENSITIVITY IN CHILDREN WITH CANCER | NIH | 2009 | 07-14-2009 | $ 225,927 |
| 071284913 | 2R01AI037093-12A2 | CHARACTERIZATION OF HUMAN CALICIVIRUSES | NIH | 2009 | 08-28-2009 | $ 408,998 |
| 071284913 | 2R56DK047318-13 | EXPRESSION AND FUNCTION OF THE GUANYLIN LIGAND FAMILY | NIH | 2010 | 07-28-2010 | $ 381,250 |
| 071284913 | 3K23CA117864-04S1 | IMPROVING PARENT/ADOLESCENT COMMUNICATION ABOUT TOBACCO | NIH | 2009 | 09-22-2009 | $ 49,926 |
| 071284913 | 3K24DK059492-09S1 | BEHAVIORAL RX & NUTRITION IN PEDIATRIC CHRONIC DISEASE | NIH | 2009 | 09-07-2009 | $ 54,000 |
| 071284913 | 3P30AR047363-10S1 | CINCINNATI RHEUMATIC DISEASE CORE CENTER | NIH | 2010 | 09-10-2010 | $ 386,385 |
| 071284913 | 3P30DK078392-03S1 | DIGESTIVE HEALTH CENTER: BENCH TO BEDSIDE RESEARCH IN PEDIATRIC DIGESTIVE DISEAS | NIH | 2009 | 07-16-2009 | $ 294,200 |
| 071284913 | 3P50NS057531-01A2S1 | CINCINNATI CENTER OF NEUROFIBROMATOSIS RESEARCH | NIH | 2009 | 09-03-2009 | $ 197,229 |
| 071284913 | 3R01AI057753-05S1 | REGULATION OF APOPTOSIS IN ACTIVATED PRIMARY T CELLS | NIH | 2010 | 06-28-2010 | $ 102,311 |
| 071284913 | 3R01AI073713-02S1 | BEHAVIORAL AND VIROLOGIC IMPACT OF HPV IMMUNIZATION | NIH | 2009 | 06-17-2009 | $ 15,000 |
| 071284913 | 3R01CA116316-04S1 | ROLE AND REGULATON OF THE HUMAN DEK PROTO-ONCOGENE | NIH | 2009 | 09-02-2009 | $ 219,317 |
| 071284913 | 3R01CA125658-03S1 | RAC GTPASES AS TARGETS IN LYMPHOMAGENESIS | NIH | 2009 | 09-29-2009 | $ 645,498 |
| 071284913 | 3R01DA019965-04S1 | INNOVATIVE MODELING OF PUBERTY AND SUBSTANCE USE RISK | NIH | 2009 | 05-29-2009 | $ 15,000 |
| 071284913 | 3R01DC007696-02S1 | NUCLEAR MODIFIER GENES FOR MATERNALLY INHERITED DEAFNESS | NIH | 2009 | 05-29-2009 | $ 15,000 |
| 071284913 | 3R01DC008651-03S1 | A PRECLINICAL TRIAL OF INTRATYMPANIC ANTIVIRALS FOR CMV-RELATED HEARING LOSS | NIH | 2009 | 07-15-2009 | $ 257,768 |
| 071284913 | 3R01DK036729-23S1 | STUDIES OF GAUCHER DISEASE: A PROTOTYPE LIPIDOSIS | NIH | 2009 | 06-05-2009 | $ 7,500 |
| 071284913 | 3R01DK036729-24S2 | STUDIES OF GAUCHER DISEASE: A PROTOTYPE LIPIDOSIS | NIH | 2010 | 03-17-2010 | $ 101,500 |
| 071284913 | 3R01DK054915-10S1 | BEHAVIORAL & NUTRITION TX TO HELP CF PRESCHOOLERS GROW | NIH | 2010 | 09-30-2010 | $ 57,690 |
| 071284913 | 3R01DK067255-05S1 | MECHANISTIC ANALYSIS OF EOSINOPHILIC ESOPHAGITIS. | NIH | 2009 | 07-13-2009 | $ 30,000 |
| 071284913 | 3R01DK068463-05S1 | INTRALUMENTAL EFFECT ON CHOLESTEROL ABSORPTION/SYNTHESIS | NIH | 2009 | 08-31-2009 | $ 99,999 |
| 071284913 | 3R01DK069486-03S1 | SELF-MANAGEMENT OF TYPE 1 DIABETES DURING ADOLESCENCE | NIH | 2009 | 07-15-2009 | $ 29,639 |
| 071284913 | 3R01DK076893-03S1 | IL-13 AND EOSINOPHILIC ESOPHAGITIS | NIH | 2009 | 09-29-2009 | $ 1,580,324 |
| 071284913 | 3R01DK080020-02S1 | ADOLESCENT BARIATRICS: CONTROLLED LONGITUDINAL STUDY OF PSYCHOSOCIAL DEVELOPMENT | NIH | 2010 | 01-07-2010 | $ 77,817 |
| 071284913 | 3R01DK080823-01A1S1 | MAMMALIAN FOREGUT AND LIVER DEVELOPMENT | NIH | 2009 | 08-12-2009 | $ 99,999 |
| 071284913 | 3R01GM064619-06S1 | GENOMIC ANALYSIS OF PEDIATRIC SIRS AND SEPTIC SHOCK | NIH | 2009 | 09-24-2009 | $ 275,026 |
| 071284913 | 3R01HD038578-10S1 | FMRI OF NORMAL LANGUAGE DEVELOPMENT IN CHILDREN | NIH | 2010 | 07-27-2010 | $ 108,752 |
| 071284913 | 3R01HD052533-03S1 | PREVENTING TEEN PREGNANCY: PREPREGNANCY PSYCHOSOCIAL MECHANISMS FOR AT-RISK FEMAL | NIH | 2009 | 07-13-2009 | $ 7,500 |
| 071284913 | 3R01HD052533-04S1 | PREVENTING TEEN PREGNANCY: PREPREGNANCY PSYCHOSOCIAL MECHANISMS FOR AT-RISK FEMAL | NIH | 2010 | 05-03-2010 | $ 7,605 |
| 071284913 | 3R01HD059140-01S1 | NOVEL GENETIC AND SALIVARY GLYCAN BIOMARKERS FOR RISK OF NEC IN ELBW INFANTS. | NIH | 2009 | 09-29-2009 | $ 59,916 |
| 071284913 | 3R01HL076712-04S1 | ROLE OF FA PROTEINS IN HEMATOPOIESIS | NIH | 2009 | 07-30-2009 | $ 114,540 |
| 071284913 | 3R01HL079193-05S1 | ROLE OF RB FAMILY IN LUNG EPITHELIAL RESPONSE TO INJURY | NIH | 2009 | 05-29-2009 | $ 12,600 |
| 071284913 | 3R01HL079193-05S2 | ROLE OF RB FAMILY IN LUNG EPITHELIAL RESPONSE TO INJURY | NIH | 2009 | 07-15-2009 | $ 84,323 |
| 071284913 | 3R01HL079574-06S1 | MOLECULAR MECHANISM OF SEVERE CONGENITAL NEUTROPENIA | NIH | 2009 | 07-31-2009 | $ 242,753 |
| 071284913 | 3R01HL084082-03S1 | FUNCTION AND REGULATION OF FANCM IN FANCONI ANEMIA | NIH | 2009 | 07-30-2009 | $ 242,069 |
| 071284913 | 3R01HL085545-04S1 | MECHANISMS LINKING METASTASIS TO TUMOR PROCOAGULANT AND INNATE IMMUNITY | NIH | 2009 | 07-31-2009 | $ 225,351 |
| 071284913 | 3R01HL085587-02S1 | FANCD2 MONOUBIQUITINATION IN DNA DAMAGE RESPONSES | NIH | 2009 | 07-30-2009 | $ 233,084 |
| 071284913 | 3R01HL086598-03S1 | EPIDERMAL GROWTH FACTOR RECEPTOR ACTIVATION IN PULMONARY FIBROSIS | NIH | 2009 | 06-05-2009 | $ 15,000 |
| 071284913 | 3R01HL086598-03S2 | EPIDERMAL GROWTH FACTOR RECEPTOR ACTIVATION IN PULMONARY FIBROSIS | NIH | 2009 | 07-16-2009 | $ 244,686 |
| 071284913 | 3R01HL087159-01A2S1 | RAC GTPASE INHIBITION IN CHRONIC MYELOGENOUS LEUKEMIA | NIH | 2009 | 07-30-2009 | $ 213,217 |
| 071284913 | 3R01HL088639-03S1 | ROLE OF THE EMBRYONIC NODE IN CARDIAC DEVELOPMENT AND CONGENITAL HEART DISEASE | NIH | 2009 | 07-15-2009 | $ 171,970 |
| 071284913 | 3R01HL091769-03S1 | AN ANIMAL MODEL OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS | NIH | 2009 | 07-30-2009 | $ 249,023 |
| 071284913 | 3R01NS028840-19S1 | MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS | NIH | 2009 | 09-17-2009 | $ 80,750 |
| 071284913 | 3R01NS050536-04S1 | DRUG & NON-DRUG TREATMENT OF PEDIATRIC CHRONIC HEADACHE | NIH | 2009 | 09-24-2009 | $ 63,900 |
| 071284913 | 3R21AI081083-01S1 | NEURONAL REGULATION OF HSV LYTIC AND LATENT INFECTION | NIH | 2009 | 09-07-2009 | $ 144,411 |
| 071284913 | 3R21HD059823-01S1 | THERAPY OF NEURONOPATHIC GAUCHER DISEASE | NIH | 2009 | 07-10-2009 | $ 6,300 |
| 071284913 | 3R21HD059823-02S1 | THERAPY OF NEURONOPATHIC GAUCHER DISEASE | NIH | 2010 | 05-05-2010 | $ 6,388 |
| 071284913 | 3R21HL093683-01A1S1 | MECHANISM OF VASOPRESSIN-MEDIATED PLACENTAL VASCULAR RESISTANCE AFTER FETAL BYPAS | NIH | 2009 | 07-15-2009 | $ 182,794 |
| 071284913 | 3R21HL093706-01A1S1 | NOVEL MODEL OF ADULT LUNG EPITHELIAL STEM CELL EXPANSION | NIH | 2009 | 06-03-2009 | $ 7,500 |
| 071284913 | 3R37AI024717-23S1 | GENETIC LINKAGE IN LUPUS | NIH | 2011 | 01-21-2011 | $ 153,900 |
| 071284913 | 3R37HD012304-30S2 | ASPECTS OF BLASTOCYST IMPLANTATION | NIH | 2010 | 07-29-2010 | $ 108,724 |
| 071284913 | 3U01AI067150-05S1 | HLA/KIR REGION GENETICS IN PEDIATRIC ARTHRITIS | NIH | 2010 | 12-14-2009 | $ 4,005 |
| 071284913 | 3U01AI067150-05S2 | HLA/KIR REGION GENETICS IN PEDIATRIC ARTHRITIS | NIH | 2010 | 06-28-2010 | $ 271,614 |
| 071284913 | 3U01AI088806-01S1 | A MULTI-CENTER CLINICAL TRIAL OF 1760 MCG OF DAILY SWALLOWED FLUTICASONE VS. PLAC | NIH | 2010 | 06-28-2010 | $ 137,250 |
| 071284913 | 3U01AR055054-03S1 | EFFICACY MEASURES FOR PEDIATRIC LUPUS STUDIES | NIH | 2009 | 09-16-2009 | $ 131,716 |
| 071284913 | 3U01DK062497-08S1 | CLINICAL CENTER FOR CHOLESTATIC LIVER DISEASE IN CHILDREN | NIH | 2010 | 02-02-2010 | $ 109,981 |
| 071284913 | 3U01DK072493-04S1 | ADOLESCENT BARIATRICS: ASSESSING HEALTH BENEFITS & RISKS | NIH | 2009 | 09-17-2009 | $ 155,376 |
| 071284913 | 3U01DK072493-05S1 | ADOLESCENT BARIATRICS: ASSESSING HEALTH BENEFITS & RISKS | NIH | 2010 | 06-19-2010 | $ 305,862 |
| 071284913 | 3U01DK072493-05S2 | ADOLESCENT BARIATRICS: ASSESSING HEALTH BENEFITS & RISKS | NIH | 2010 | 06-14-2010 | $ 297,846 |
| 071284913 | 3U10HD037249-10S1 | CHMCC PEDIATRIC PHARMACOLOGY RESEARCH UNIT | NIH | 2009 | 07-16-2009 | $ 151,476 |
| 071284913 | 3U19AI070235-03S1 | EPITHELIAL GENES IN ALLERGIC INFLAMMATION | NIH | 2009 | 08-11-2009 | $ 450,000 |
| 071284913 | 5P30CA149239-02 | CINCINNATI NEURO-ONCOLOGY RESEARCH CORE | NIH | 2010 | 09-07-2010 | $ 710,000 |
| 071284913 | 5P30HL101333-02 | DEVELOPMENT OF AN ASTHMA RESEARCH CORE CENTER | NIH | 2010 | 09-15-2010 | $ 445,662 |
| 071284913 | 5R01AG033057-02 | HOMEOSTASIS AND FUNCTION OF REGULATORY T CELLS IN AGING | NIH | 2010 | 09-10-2010 | $ 472,528 |
| 071284913 | 5R01AI037093-13 | CHARACTERIZATION OF HUMAN CALICIVIRUSES | NIH | 2010 | 08-04-2010 | $ 396,498 |
| 071284913 | 5R01AI078969-02 | INNATE IMMUNE RESPONSES DURING TOXOPLASMOSIS | NIH | 2010 | 08-02-2010 | $ 381,459 |
| 071284913 | 5R01AI080581-02 | ROLE OF IL-15 IN THE PATHOGENESIS OF EOSINOPHILIC ESOPHAGITIS (EE) | NIH | 2010 | 06-07-2010 | $ 371,814 |
| 071284913 | 5R01CA140518-02 | THE ROLE OF MLL-AF9 IN ACUTE MYELOID LEUKEMIA | NIH | 2010 | 06-30-2010 | $ 370,898 |
| 071284913 | 5R01DK081489-02 | GLOMERULOSCLEROSIS IN HUMAN FSGS AND ANIMAL MODELS | NIH | 2010 | 09-13-2010 | $ 353,240 |
| 071284913 | 5R01ES015517-02 | NEUROBEHAVIORAL EFFECTS OF INSECTICIDE EXPOSURE IN PREGNANCY AND EARLY CHILDHOOD | NIH | 2010 | 07-13-2010 | $ 744,877 |
| 071284913 | 5R01EY019377-02 | CRIM1-B-CATENIN-CADHERIN INTERACTIONS IN EYE DEVELOPMENT AND DISEASE | NIH | 2010 | 07-02-2010 | $ 373,445 |
| 071284913 | 5R01HD056044-02 | MOLECULAR SIGNALING IN DECIDUALIZATION | NIH | 2010 | 07-14-2010 | $ 524,860 |
| 071284913 | 5R01HD060578-02 | THE ROLES OF STEEL FACTOR IN GERM CELL BEHAVIOR IN THE MOUSE | NIH | 2010 | 06-09-2010 | $ 373,047 |
| 071284913 | 5R01HD065277-02 | 2/2 DEVELOPMENT OF A SCREENING INTERVIEW FOR RESEARCH STUDIES OF ASD | NIH | 2010 | 09-07-2010 | $ 372,239 |
| 071284913 | 5R01HL094319-02 | WNT SIGNALING IN HEART VALVE DEVELOPMENT AND DISEASE | NIH | 2010 | 06-15-2010 | $ 454,086 |
| 071284913 | 5R01HL097360-02 | DIRECT IL-4 AND IL-13 EFFECTS ON PULMONARY SMOOTH MUSCLE IN ALLERGIC AIRWAY DISEA | NIH | 2010 | 08-12-2010 | $ 476,818 |
| 071284913 | 5R03NS064378-02 | SHORT AND LONG-TERM IMPACT OF NEONATAL SEIZURES ON HIPPOCAMPAL GRANULE CELL INTEG | NIH | 2010 | 05-21-2010 | $ 75,000 |
| 071284913 | 5R21AI076746-02 | IDENTIFICATION OF GENES INVOLVED IN FHLH | NIH | 2010 | 08-02-2010 | $ 190,729 |
| 071284913 | 5R21AI083599-02 | RELM PEPTIDES ALTER LUNG DEFENSE | NIH | 2010 | 08-11-2010 | $ 228,875 |
| 071284913 | 5R21DA025312-02 | METABOLIC CONSEQUENCES OF SUBSTANCE USE IN ADOLESCENT GIRLS | NIH | 2010 | 04-26-2010 | $ 187,500 |
| 071284913 | 5R21ES016830-02 | EXPOSURE-INDUCED SYSTEMIC OXIDATIVE STRESS IN CHILDREN WITH ASTHMA | NIH | 2010 | 05-28-2010 | $ 177,634 |
| 071284913 | 5R21NS064352-02 | THERAPY OF GAUCHER DISEASE: IN VIVO ENHANCEMENT OF RESIDUAL MUTANT ACTIVITY | NIH | 2010 | 04-09-2010 | $ 222,176 |
| 071284913 | 5RC1AI087336-02 | UNBIASED FORWARD GENETIC ANALYSIS OF VIRUS/HOST INTERACTIONS | NIH | 2010 | 08-11-2010 | $ 436,320 |
| 071284913 | 5RC1AR058587-02 | DEFINING THE COMPLEX GENETICS OF JIA | NIH | 2010 | 08-06-2010 | $ 500,000 |
| 071284913 | 5RC1HL100315-02 | UNBIASED GENOME-WIDE SCREEN TO IDENTIFY GENES REGULATING MUCOUS CELL HYPERPLASIA | NIH | 2010 | 08-13-2010 | $ 405,762 |
| 071284913 | 5RC1HL100474-02 | THE PEDIATRIC SEPSIS BIOMARKER RISK MODEL | NIH | 2010 | 08-13-2010 | $ 499,593 |
| 071284913 | 5U01AI088806-02 | A MULTI-CENTER CLINICAL TRIAL OF 1760 MCG OF DAILY SWALLOWED FLUTICASONE VS. PLAC | NIH | 2010 | 07-19-2010 | $ 309,659 |
| 071284913 | 5U01CA139275-02 | PREDICTION MODEL FOR RADIATION SENSITIVITY IN CHILDREN WITH CANCER | NIH | 2010 | 07-01-2010 | $ 185,017 |
| 071284913 | 7S10RR027190-02 | ILLUMINA ISCAN SYSTEM FOR THE OMRF MICROARRAY RESEARCH FACILITY | NIH | 2010 | 08-23-2010 | $ 413,350 |
| 071284913 | R01DE015207-9-005 | GENETIC BASIS OF CLEFT LIP AND PALATE | NIH | 2011 | 07-25-2011 | $ 30,298 |
| 071284913 | R01DE018401-3-000 | MOLECULAR PATTERNING OF MAMMALIAN DENTITION | NIH | 2011 | 07-22-2011 | $ 11,801 |
| 071284913 | R01HS020024-1-001 | BUILDING MODULAR PEDIATRIC CHRONIC DISEASE REGISTRIES FOR QI AND CE RESEARCH | AHRQ | 2011 | 09-20-2011 | $- 138,678 |
| 071284913 | U01AI067150-5-002 | HLA/KIR REGION GENETICS IN PEDIATRIC ARTHRITIS | NIH | 2009 | 08-28-2009 | $ 301,074 |
To continue, click on the Award Title in the list above to obtain detailed data about a specific Award.
The Award Detail screen should display with the data for that award that is available for reporting to FederalReporting.gov.
DISCLAIMER
The data contained in the HHS Recipient Readiness Tool reflects the best available data for HHS grant programs that are subject to Recovery Act Recipient Reporting. Please note that according to OMB supplemental guidance recipients are not required to report on awards less than $25,000 on FederalReporting.gov. For a list of programs that must be reported to FederalReporting.gov please visit Appendix 1 of the June 22nd OMB guidance. For additional questions or concerns on reporting requirements for your award please contact your grants management specialist.
Data are refreshed every 24 hours. Awards issued near the end of the reporting period may not be available for 72 hours pending the timeliness of HHS Agency data transmission. If you are unable to locate your data please contact your grants management specialist.
